Ridgecrest Wealth Partners LLC Has $358,000 Holdings in The Clorox Company (NYSE:CLX)

Ridgecrest Wealth Partners LLC trimmed its stake in shares of The Clorox Company (NYSE:CLX) by 24.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,204 shares of the company’s stock after selling 725 shares during the period. Ridgecrest Wealth Partners LLC’s holdings in Clorox were worth $358,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in CLX. Mizuho Securities USA LLC lifted its stake in Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after acquiring an additional 4,490,421 shares in the last quarter. Ilex Capital Partners UK LLP raised its holdings in shares of Clorox by 512.7% in the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock valued at $88,315,000 after purchasing an additional 453,624 shares during the last quarter. International Assets Investment Management LLC lifted its position in shares of Clorox by 424.9% in the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock worth $877,390,000 after purchasing an additional 435,971 shares in the last quarter. Boston Trust Walden Corp boosted its holdings in Clorox by 5,442.5% during the third quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock worth $44,622,000 after purchasing an additional 268,966 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its position in Clorox by 302.0% in the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock valued at $57,390,000 after purchasing an additional 265,455 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. JPMorgan Chase & Co. boosted their price target on shares of Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research report on Thursday, January 16th. Barclays reduced their price target on Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research report on Friday, January 17th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and boosted their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, Evercore ISI lowered their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $156.54.

Clorox Stock Performance

NYSE CLX opened at $159.12 on Monday. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The stock has a market cap of $19.70 billion, a PE ratio of 55.44, a P/E/G ratio of 2.92 and a beta of 0.42. The firm has a 50-day moving average of $163.66 and a 200-day moving average of $157.66. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the business posted $0.49 earnings per share. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. On average, sell-side analysts anticipate that The Clorox Company will post 6.87 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is 170.04%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.